Priced to hit targets and keep growing. To access the full report please log in under the Client Area at the bottom of this page. Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists. If you wouldRead more
Key News Overnight: U.S. stocks ended down on Tuesday, slumping on a sharp decline in telecom stocks and weak housing starts data that overshadowed better-than-expected earnings from Walmart and Home Depot. The Dow Jones Industrial Average fell 267 points, or 0.8%, to 34,061, the S&P 500 lost 35 points, or 0.9%, to 4,128 and theRead more
Argonaut has reviewed quarterly results for select WA gold developers. WA gold developers remain well funded, with access to additional capital as needed. Year-on-year quarterly exploration spend is around double what it was last year, and appears to be steady. Projects are progressing, both through development studies and Resource updates adding to inventories. To accessRead more
Bardoc, with a large and prospective land holding, and a strong team with a background in developing and operating mines within the Kalgoorlie district, will be amongst the next wave of mid-tier gold producers. An increased mining inventory to draw upon is a matter of more drilling as its namesake project advances towards planned firstRead more
Recent contract wins and conservative pipeline assumptions underpin our medium-term revenue upgrades. We expect discipline in support of new and potential pipeline projects and for the return on deployed capital to exceed its cost despite emerging mining sector cost pressures and potential currency risk. Valuation upside underpins our BUY call. To access the full reportRead more
Alberta’s coal policy schemozzle sets Atrum back a year or two. To access the full report please log in under the Client Area at the bottom of this page. Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watchRead more
Exposure to US and Australian naval defence spending, upcoming investment to grow capability and sustainment earnings, and a strong cash position are key positives. Although we pencil in a medium-term dip in US revenue, we think this will be a temporary and manageable lull between ship programmes. Our valuation of $3.35 (prior $3.85) reflects theRead more
The share price drop provides investors an attractive opportunity to invest in a business positioned to grow. We expect disciplined management of capital in converting new work opportunities during growth periods and strong free cash flow at steady state. Guidance has consistently been met, although currency movements pose a risk. We maintain a BUY callRead more
For more information contact your Broker directly or Argonaut on +61 8 9224 6888Read more
BOT announced positive results from its BTX 1801 Phase 2a nasal decolonisation proof of concept study. We upgrade to SPEC BUY (prior HOLD) as these results highlight CBD’s potential as a new treatment for resistant bacteria. To access the full report please log in under the Client Area at the bottom of this page. Argonaut’sRead more
